NCT06513442View on ClinicalTrials.gov

The Added Value of Bone Microstructure Assessment in the Management of Osteoporotic Bone

Not yet recruitingOBSERVATIONAL

Enrollment

1,500

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

August 1, 2034

Study Completion Date

August 1, 2034

Conditions

Osteoporosis

Interventions

OTHER

Trabecular bone score software

To assess the clinical utility of trabecular bone score (TBS) on fracture risk prediction including the new version (TBS V4) and future TBS versions at the spine and hip.

All Listed Sponsors

lead

Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust

OTHER_GOV

NCT06513442 - The Added Value of Bone Microstructure Assessment in the Management of Osteoporotic Bone | Biotech Hunter | Biotech Hunter